Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in the research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.
Company Information
About this company
Key people
Craig Jonathan Gulliford
Chief Executive Officer, Executive Director
Richard John Rees
Chief Financial Officer, Executive Director
Christopher Paul Hancock
Chief Technology Officer, Executive Director
David Gerard Woods
Chief Commercial Officer, Executive Director
Kevin Timothy Crofton
Non-Executive Independent Chairman of the Board
Brent J. Boucher
Independent Non-Executive Director
Ivonne Maria Gloria Cantu
Independent Non-Executive Director
Click to see more
Key facts
- Shares in issue412.47m
- EPICCREO
- ISINGB00BZ1BLL44
- LocationUnited Kingdom
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap£44.44m
- Employees133
- ExchangeLondon Stock Exchange (LON)
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.